Statins and Blood Coagulation
- 1 February 2005
- journal article
- review article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 25 (2), 287-294
- https://doi.org/10.1161/01.atv.0000151647.14923.ec
Abstract
The 3-hydroxy-3-methylglutaryl (HMG)-coenzyme A (CoA) reductase inhibitors (statins) have been shown to exhibit several vascular protective effects, including antithrombotic properties, that are not related to changes in lipid profile. There is growing evidence that treatment with statins can lead to a significant downregulation of the blood coagulation cascade, most probably as a result of decreased tissue factor expression, which leads to reduced thrombin generation. Accordingly, statin use has been associated with impairment of several coagulant reactions catalyzed by this enzyme. Moreover, evidence indicates that statins, via increased thrombomodulin expression on endothelial cells, may enhance the activity of the protein C anticoagulant pathway. Most of the antithrombotic effects of statins are attributed to the inhibition of isoprenylation of signaling proteins. These novel properties of statins, suggesting that these drugs might act as mild anticoagulants, may explain, at least in part, the therapeutic benefits observed in a wide spectrum of patients with varying cholesterol levels, including subjects with acute coronary events.Keywords
This publication has 65 references indexed in Scilit:
- Arteriosclerosis, Thrombosis, and Vascular Biology , 2004Arteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulationBlood Coagulation & Fibrinolysis, 2003
- Statins differ in their ability to block NF-kB activation in human blood monocytesInt. Journal of Clinical Pharmacology and Therapeutics, 2003
- Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysisBMJ, 2003
- Pitavastatin-Induced Thrombomodulin Expression by Endothelial Cells Acts Via Inhibition of Small G Proteins of the Rho FamilyArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Effects of HMG-CoA Reductase Inhibitors on Coagulation and Fibrinolysis ProcessesDrugs, 2003
- Statins and the risk of idiopathic venous thromboembolismBritish Journal of Clinical Pharmacology, 2002
- Elevated plasma levels of free-form of TFPI antigen in hypercholesterolemic patientsAtherosclerosis, 2001
- State-of-the-Art-Review : Statins Induce Hypothrombotic States?Clinical and Applied Thrombosis/hemostasis, 2000
- Lovastatin Therapy in Hypercholesterolemia: Effect on Fibrinogen, Hemorrheologic Parameters, Platelet Activity, and Red Blood Cell MorphologyThe Journal of Clinical Pharmacology, 1991